Cargando…

High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data

BACKGROUND: Coronavirus disease 2019 (COVID-19) disease can frequently affect the liver. Data on hepatic histopathological findings in COVID-19 is scarce. AIM: To characterize hepatic pathological findings in patients with COVID-19. METHODS: We conducted a systematic review with meta-analysis regist...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz, Luis Antonio, Idalsoaga, Francisco, Cannistra, Macarena, Candia, Roberto, Cabrera, Daniel, Barrera, Francisco, Soza, Alejandro, Graham, Rondell, Riquelme, Arnoldo, Arrese, Marco, Leise, Michael D, Arab, Juan Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789052/
https://www.ncbi.nlm.nih.gov/pubmed/33505145
http://dx.doi.org/10.3748/wjg.v26.i48.7693
_version_ 1783633155541958656
author Díaz, Luis Antonio
Idalsoaga, Francisco
Cannistra, Macarena
Candia, Roberto
Cabrera, Daniel
Barrera, Francisco
Soza, Alejandro
Graham, Rondell
Riquelme, Arnoldo
Arrese, Marco
Leise, Michael D
Arab, Juan Pablo
author_facet Díaz, Luis Antonio
Idalsoaga, Francisco
Cannistra, Macarena
Candia, Roberto
Cabrera, Daniel
Barrera, Francisco
Soza, Alejandro
Graham, Rondell
Riquelme, Arnoldo
Arrese, Marco
Leise, Michael D
Arab, Juan Pablo
author_sort Díaz, Luis Antonio
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) disease can frequently affect the liver. Data on hepatic histopathological findings in COVID-19 is scarce. AIM: To characterize hepatic pathological findings in patients with COVID-19. METHODS: We conducted a systematic review with meta-analysis registered on PROSPERO (CRD42020192813), following PRISMA guidelines. Eligible trials were those including patients of any age and COVID-19 diagnosis based on a molecular test. Histopathological reports from deceased COVID-19 patients undergoing autopsy or liver biopsy were reviewed. Articles including less than ten patients were excluded. Proportions were pooled using random-effects models. Q statistic and I(2) were used to assess heterogeneity and levels of evidence, respectively. RESULTS: We identified 18 studies from 7 countries; all were case reports and case series from autopsies. All the patients were over 15 years old, and 67.2% were male. We performed a meta-analysis of 5 studies, including 116 patients. Pooled prevalence estimates of liver histopathological findings were hepatic steatosis 55.1% [95% confidence interval (CI): 46.2-63.8], congestion of hepatic sinuses 34.7% (95%CI: 7.9-68.4), vascular thrombosis 29.4% (95%CI: 0.4-87.2), fibrosis 20.5% (95%CI: 0.6-57.9), Kupffer cell hyperplasia 13.5% (95%CI: 0.6-54.3), portal inflammation 13.2% (95%CI: 0.1-48.8), and lobular inflammation 11.6% (95%CI: 0.3-35.7). We also identified the presence of venous outflow obstruction, phlebosclerosis of the portal vein, herniated portal vein, periportal abnormal vessels, hemophagocytosis, and necrosis. CONCLUSION: We found a high prevalence of hepatic steatosis and vascular thrombosis as major histological liver features. Other frequent findings included portal and lobular inflammation and Kupffer cell hyperplasia or proliferation. Further studies are needed to establish the mechanisms and implications of these findings.
format Online
Article
Text
id pubmed-7789052
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-77890522021-01-26 High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data Díaz, Luis Antonio Idalsoaga, Francisco Cannistra, Macarena Candia, Roberto Cabrera, Daniel Barrera, Francisco Soza, Alejandro Graham, Rondell Riquelme, Arnoldo Arrese, Marco Leise, Michael D Arab, Juan Pablo World J Gastroenterol Systematic Reviews BACKGROUND: Coronavirus disease 2019 (COVID-19) disease can frequently affect the liver. Data on hepatic histopathological findings in COVID-19 is scarce. AIM: To characterize hepatic pathological findings in patients with COVID-19. METHODS: We conducted a systematic review with meta-analysis registered on PROSPERO (CRD42020192813), following PRISMA guidelines. Eligible trials were those including patients of any age and COVID-19 diagnosis based on a molecular test. Histopathological reports from deceased COVID-19 patients undergoing autopsy or liver biopsy were reviewed. Articles including less than ten patients were excluded. Proportions were pooled using random-effects models. Q statistic and I(2) were used to assess heterogeneity and levels of evidence, respectively. RESULTS: We identified 18 studies from 7 countries; all were case reports and case series from autopsies. All the patients were over 15 years old, and 67.2% were male. We performed a meta-analysis of 5 studies, including 116 patients. Pooled prevalence estimates of liver histopathological findings were hepatic steatosis 55.1% [95% confidence interval (CI): 46.2-63.8], congestion of hepatic sinuses 34.7% (95%CI: 7.9-68.4), vascular thrombosis 29.4% (95%CI: 0.4-87.2), fibrosis 20.5% (95%CI: 0.6-57.9), Kupffer cell hyperplasia 13.5% (95%CI: 0.6-54.3), portal inflammation 13.2% (95%CI: 0.1-48.8), and lobular inflammation 11.6% (95%CI: 0.3-35.7). We also identified the presence of venous outflow obstruction, phlebosclerosis of the portal vein, herniated portal vein, periportal abnormal vessels, hemophagocytosis, and necrosis. CONCLUSION: We found a high prevalence of hepatic steatosis and vascular thrombosis as major histological liver features. Other frequent findings included portal and lobular inflammation and Kupffer cell hyperplasia or proliferation. Further studies are needed to establish the mechanisms and implications of these findings. Baishideng Publishing Group Inc 2020-12-28 2020-12-28 /pmc/articles/PMC7789052/ /pubmed/33505145 http://dx.doi.org/10.3748/wjg.v26.i48.7693 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Systematic Reviews
Díaz, Luis Antonio
Idalsoaga, Francisco
Cannistra, Macarena
Candia, Roberto
Cabrera, Daniel
Barrera, Francisco
Soza, Alejandro
Graham, Rondell
Riquelme, Arnoldo
Arrese, Marco
Leise, Michael D
Arab, Juan Pablo
High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data
title High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data
title_full High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data
title_fullStr High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data
title_full_unstemmed High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data
title_short High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data
title_sort high prevalence of hepatic steatosis and vascular thrombosis in covid-19: a systematic review and meta-analysis of autopsy data
topic Systematic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789052/
https://www.ncbi.nlm.nih.gov/pubmed/33505145
http://dx.doi.org/10.3748/wjg.v26.i48.7693
work_keys_str_mv AT diazluisantonio highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata
AT idalsoagafrancisco highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata
AT cannistramacarena highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata
AT candiaroberto highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata
AT cabreradaniel highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata
AT barrerafrancisco highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata
AT sozaalejandro highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata
AT grahamrondell highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata
AT riquelmearnoldo highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata
AT arresemarco highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata
AT leisemichaeld highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata
AT arabjuanpablo highprevalenceofhepaticsteatosisandvascularthrombosisincovid19asystematicreviewandmetaanalysisofautopsydata